We are live on
!
Find out more
Alyeska Investment Group Portfolio holdings
AUM
$35.4B
1-Year Est. Return
33.54%
This Fund
S&P 500
This Quarter
Est. Return
+13.49%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$15.1B
AUM Growth
+$367M
(+2.5%)
Cap. Flow
-$1.2B
Cap. Flow
% of AUM
-7.98%
Top 10 Holdings %
Top 10 Hldgs %
15.48%
Holding
700
New
227
Increased
111
Reduced
135
Closed
190
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$220M |
| 2 |
Estee Lauder
EL
|
+$166M |
| 3 |
Autodesk
ADSK
|
+$153M |
| 4 |
Texas Instruments
TXN
|
+$140M |
| 5 |
Dell
DELL
|
+$134M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$192M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$187M |
| 3 |
Analog Devices
ADI
|
+$178M |
| 4 |
lululemon athletica
LULU
|
+$171M |
| 5 |
Hershey
HSY
|
+$131M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.54% |
| 2 | Consumer Discretionary | 14.27% |
| 3 | Healthcare | 14.13% |
| 4 | Industrials | 12.15% |
| 5 | Financials | 8.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Arhaus
ARHS
$1.34B
| $1.19M | 0.01% |
+100,000
| New | +$942K |
|
|
SPRB
402
Spruce Biosciences
SPRB
$127M
| $1.17M | 0.01% |
5,333
-8,000
| -60% | -$924K |
|
403
CALL
Alvotech
ALVO
$1.28B
| $1.15M | 0.01% |
+100,000
| New | +$944K |
|
404
CALL
IN8bio
INAB
$9.61M
| $1.13M | 0.01% |
+27,322
| New | +$873K |
|
|
405
IN8bio
INAB
$9.61M
| $1.12M | 0.01% |
+27,322
| New | +$873K |
|
406
Tonix Pharmaceuticals
TNXP
$201M
| $1.09M | 0.01% |
+845
| New | +$1.36M |
|
407
AN2 Therapeutics
ANTX
$213M
| $1.02M | 0.01% |
50,000
| – | – |
|
|
FNA
408
DELISTED
Paragon 28, Inc.
FNA
| $1.02M | 0.01% |
82,192
| – | – |
|
409
Pentair
PNR
$10.7B
| $919K | 0.01% |
+12,635
| New | +$815K |
|
410
Cytek Biosciences
CTKB
$606M
| $912K | 0.01% |
100,000
| – | – |
|
|
FATH
411
CALL
DELISTED
Fathom Digital Manufacturing Corporation
FATH
| $905K | 0.01% |
+202,934
| New | +$880K |
|
412
Norfolk Southern
NSC
$75B
| $831K | 0.01% |
+3,517
| New | +$737K |
|
413
General Dynamics
GD
$107B
| $813K | 0.01% |
+3,130
| New | +$764K |
|
414
CALL
Waldencast
WALD
$178M
| $798K | 0.01% |
+72,921
| New | +$689K |
|
415
East-West Bancorp
EWBC
$18.1B
| $783K | 0.01% |
+10,887
| New | +$656K |
|
|
MRSH
416
Marsh
MRSH
$91B
| $747K | 0.01% |
3,945
-66,285
| -94% | -$12.8M |
|
417
JB Hunt Transport Services
JBHT
$25B
| $730K | ﹤0.01% |
+3,654
| New | +$677K |
|
418
CALL
Viridian Therapeutics
VRDN
$2.61B
| $720K | ﹤0.01% |
+33,063
| New | +$522K |
|
419
Caribou Biosciences
CRBU
$165M
| $716K | ﹤0.01% |
125,000
| – | – |
|
420
CALL
Taboola.com
TBLA
$1.12B
| $693K | ﹤0.01% |
+160,000
| New | +$604K |
|
421
Advanced Micro Devices
AMD
$767B
| $681K | ﹤0.01% |
4,620
+620
| +16% | +$73.1K |
|
422
Aura Biosciences
AURA
$796M
| $672K | ﹤0.01% |
+75,900
| New | +$643K |
|
423
CALL
Owlet
OWLT
$158M
| $660K | ﹤0.01% |
+125,000
| New | +$613K |
|
|
HLVX
424
DELISTED
HilleVax
HLVX
| $630K | ﹤0.01% |
39,265
-13,235
| -25% | -$176K |
|
425
CALL
Cellebrite
CLBT
$3.97B
| $577K | ﹤0.01% |
+66,667
| New | +$518K |
|
Similar funds
SAM
VIA
Alyeska Investment Group's Q4 2023 Portfolio in Review
As of Q4 2023, Alyeska Investment Group held 700 positions worth $15.1B, up 2.5% from $14.7B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Alyeska Investment Group withdrew a net $1.2B in Q4 2023, closing 190 positions and reducing 135 holdings. Its most notable exit was Alphabet (Google) Class A, an estimated $187M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Alyeska Investment Group opened a new position in Estee Lauder worth $183M.
- Alyeska Investment Group's largest Q4 2023 buy was Estee Lauder: 1,254,443 shares worth $183M.
- Alyeska Investment Group added most to Meta Platforms (Facebook) in Q4 2023, an estimated $220M increase.
- Alyeska Investment Group's biggest Q4 2023 reduction was Boeing, cutting an estimated $192M.
- Alyeska Investment Group fully exited Alphabet (Google) Class A in Q4 2023, selling an estimated $187M.
- Alyeska Investment Group's ten largest holdings make up 15% of its $15.1B portfolio in Q4 2023.
- Alyeska Investment Group opened 227 new positions and closed 190 in Q4 2023.
- Alyeska Investment Group's portfolio value rose 2.5% quarter-over-quarter to $15.1B.
Based on Alyeska Investment Group's 13F filing for Q4 2023, filed 14 Feb 2024.